Simplex Trading’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$131K Buy
47,700
+17,200
+56% +$53.4K ﹤0.01% 4772
2025
Q4
$95.8K Buy
30,500
+23,900
+362% +$75.4K ﹤0.01% 5043
2025
Q3
$19K Buy
+6,600
New +$14.9K ﹤0.01% 7350
2025
Q2
Sell
-700
Closed -$1K 8488
2025
Q1
$1K Sell
700
-1,200
-63% -$3.02K ﹤0.01% 8128
2024
Q4
$5K Sell
1,900
-14,400
-88% -$45K ﹤0.01% 7561
2024
Q3
$61K Sell
16,300
-63,200
-79% -$221K ﹤0.01% 5708
2024
Q2
$317K Buy
79,500
+73,500
+1,225% +$243K ﹤0.01% 4158
2024
Q1
$17K Buy
6,000
+1,500
+33% +$5.38K ﹤0.01% 7200
2023
Q4
$22K Buy
+4,500
New +$14.5K ﹤0.01% 6833
2023
Q3
Sell
-7,200
Closed -$21K 8518
2023
Q2
$21K Buy
7,200
+6,000
+500% +$13.1K ﹤0.01% 6701
2023
Q1
$2K Buy
+1,200
New +$2.78K ﹤0.01% 8405
2022
Q2
Sell
-3,800
Closed -$15K 9816
2022
Q1
$15K Sell
3,800
-10,500
-73% -$45.5K ﹤0.01% 8503
2021
Q4
$70K Buy
14,300
+12,400
+653% +$72.1K ﹤0.01% 6773
2021
Q3
$15K Hold
1,900
﹤0.01% 8646
2021
Q2
$15K Buy
1,900
+1,880
+9,400% +$13K ﹤0.01% 8806
2021
Q1
$15K Buy
+20
New +$143 ﹤0.01% 7648

Other funds holding ACIU

Simplex Trading's ACIU Position: Q1 2026 in Review

Simplex Trading opened a new position in AC Immune (ACIU) in Q1 2026: 6,620 shares worth $18.2K. The stake represents ﹤0.01% of the portfolio and ranks #6854 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ACIU as recently as Q3 2025.

Simplex Trading first reported a position in ACIU in Q3 2020 and has held it in 14 quarters since. The position peaked at $58K in Q1 2021. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Simplex Trading held 6,620 shares of AC Immune worth $18.2K as of Q1 2026.
  • AC Immune was a new Simplex Trading position in Q1 2026.
  • AC Immune made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6854 holding.
  • Simplex Trading first reported a position in AC Immune in Q3 2020 and has held it in 14 quarters since.
  • Simplex Trading's AC Immune position peaked at $58K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.